John Schmitz
Family Medicine · Ogden, UTNPI 1891782819
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.2% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations.
Across 156 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$478
- Astellas Pharma US Inc$376
- AbbVie$245
- Amarin Pharma, Inc.$185
- Lilly USA, LLC$164
- GSK$151
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,39892%
- Education$2048%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $478 |
| Astellas Pharma US Inc | 13 | $376 |
| AbbVie(2 entities) | 19 | $245 |
| Amarin Pharma, Inc. | 12 | $185 |
| Lilly USA, LLC | 13 | $164 |
| GSK | 11 | $151 |
| Sanofi-aventis U.S. LLC | 7 | $102 |
| Amgen | 5 | $87 |
| Pfizer | 6 | $75 |
| Eisai Inc. | 1 | $65 |
| Ironshore Pharmaceuticals Inc. | 3 | $46 |
| Genentech USA, Inc. | 3 | $45 |
| Boehringer Ingelheim | 3 | $43 |
| Johnson & Johnson | 3 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $37 |
| Stryker | 1 | $37 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $32 |
| Mylan Specialty L.p. | 1 | $29 |
| Boston Scientific | 2 | $27 |
| Merck | 2 | $25 |
| Abbott | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Sobi, Inc | 1 | $17 |
| Cranial Technologies, Inc | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Qiagen, LLC | 1 | $13 |
| Nalpropion Pharmaceuticals LLC | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $12 |
| Dexcom, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Shire North American Group Inc | 1 | $11 |
| Bioventus LLC | 1 | $11 |
How this compares
$2,602 in reported general payments places this provider in the 75th percentile of 928 family medicine providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 16 | $1,359 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Ogden
- Brett BlaserOgden$12K
- Nathan PhelpsOgden$11K
- James BledsoeOgden$9K
- Michael WoolmanOgden$8K
- Charles RichardsonOgden$8K
- Michael CobbleSandy$1.3M
- Thomas ClarkProvidence$332K
- Courtney NelsonLayton$190K
- David ButtersLayton$189K
- Scott EricksonBountiful$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.